Elite Pharmaceuticals, Inc. (ELTP)

OTCMKTS: ELTP · Delayed Price · USD
-0.003 (-1.91%)
Nov 27, 2023, 3:59 PM EST - Market closed

Company Description

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.

It owns, licenses, manufactures, and sells various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases.

The company also provides Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets under the Adderall brand, as well as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release capsules under the Adderall XR brand for central nervous system diseases; Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the Loxapine brand; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products.

In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, attention deficit, and infection.

Further, the company is developing a range of abuse deterrent opioid products. Elite Pharmaceuticals, Inc. was incorporated in 1997 and is headquartered in Northvale, New Jersey.

Elite Pharmaceuticals, Inc.
Country NJ
Founded 1984
IPO Date Jul 23, 1998
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 53
CEO Nasrat Hakim

Contact Details

165 Ludlow Avenue
Northvale, New Jersey 07647
United States
Phone 2017502646
Website elitepharma.com

Stock Details

Ticker Symbol ELTP
Exchange OTCMKTS
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001053369
CUSIP Number 28659T200
ISIN Number US28659T2006
Employer ID 22-3542636
SIC Code 2834

Key Executives

Name Position
Nasrat Hakim Chairman, Chief Executive Officer and Pres
Douglas Plassche Executive Vice President of Operations
Robert Chen Chief Financial Officer, Secretary and Treasurer
Dianne Will Vice President of Investor Relations and Corporate Affairs
Dr. George Kenneth Smith J.D., M.B.A., Ph.D. Vice President of Legal
Dr. Sophy Abraham Head of Regulatory Affairs
Kirko Kirkov Chief Commercial Officer

Latest SEC Filings

Date Type Title
Nov 14, 2023 8-K Current Report
Nov 14, 2023 10-Q Quarterly Report
Sep 25, 2023 8-K Current Report
Sep 7, 2023 8-K Current Report
Aug 14, 2023 8-K Current Report
Aug 14, 2023 10-Q Quarterly Report
Jul 31, 2023 10-K/A [Amend] Annual report
Jul 17, 2023 8-K Current Report
Jun 29, 2023 8-K Current Report
Jun 29, 2023 10-K Annual Report